Effects of calcium ion-implantation of titanium on bone cell function in vitro

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 2, 2007, Pages 296-302

  Nayab, Saima N ^a   Jones, Frances H ^a,b   Olsen, Irwin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bone morphogenetic protein receptor; Bone sialoprotein; MG 63 cells; Osteopontin; Surface chemistry

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE SIALOPROTEIN; MG-63 CELLS; OSTEOPONTIN;

BIOCOMPATIBILITY; BONE; CELLS; SURFACE CHEMISTRY; TITANIUM;

ION IMPLANTATION;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE SIALOPROTEIN; CALCIUM ION; MESSENGER RNA; OSTEONECTIN; OSTEOPONTIN; TITANIUM; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BONE CELL; BONE REGENERATION; CELL CULTURE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; FLOW CYTOMETRY; GENE ACTIVATION; HUMAN; HUMAN CELL; IMPLANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADOLESCENT; ANTIGENS, NEOPLASM; BONE AND BONES; CALCIUM; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MALE; MATERIALS TESTING; OSTEOPONTIN; PROSTHESES AND IMPLANTS; TITANIUM;

EID: 35048898459     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31218     Document Type: Article

References (62)

1. Esposito M, Hirsch IM, Lekholm U, Thomsen P. Biological factors contributing to failure of osseointegrated oral implants. II. Etiopathogenesis. Eur J Oral Sci 1998;106:721-764.
2. Arys A, Philippart C, Dourov N, He Y, Le QT, Pireaux JJ. Analysis of titanium dental implants after failure of osseointegration: Combined histological, electron microscopy, and X-ray photoelectron spectroscopy approach. J Biomed Mater Res 1998;43:300-312.
3. Donley, Gillete WB. Titanium endosseus implant-soft tissue interface: Literature review. J Periodontol 1991;62:153-160.
4. Long M, Rack HJ. Titanium alloys in total joint replacement - A materials science perspective. Biomaterials 1998;19:1621-1639.
5. Yoshinari M, Oda Y, Kato T, Okuda K. Influence of surface modifications to titanium on antibacterial activity in vitro. Biomaterials 2001;22:2043-2048.
6. Kasemo B, Lausmaa J. Surface science aspects on inorganic biomaterials. CRC Crit Rev Biocomp 1986;2:335-380.
7. Howlett CR, Zreiqat H, Wu Y, McFall DW, McKenzie DR. Effect of ion modification of commonly used orthopedic materials on the attachment of human bone-derived cells. J Biomed Mater Res 1999;45:345-354.
8. Puleo DA, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999;20:2311-2321.
9. Brunette DM, Tengvall P, Textor M, Thomsen P. Titanium in Medicine. New York: Springer; 2001.
10. Ratner BD, Hoffmen AS, Schoen FJ, Lemons JE. Biomaterials Science: An Introduction to Materials in Medicine. New York: Academic Press; 1996.
11. Ziegler JF. Ion Implantation; Science and Technology, 2nd ed. Boston: Academic press; 1988.
12. Hanawa T, Kamiura Y, Yamamoto S, Kohgo T, Amemiya A, Ukai H, Murakami K, Asaoka K. Early bone formation around calcium-ion-implanted titanium inserted into rat tibia. J Biomed Mater Res 1997;36:131-136.
13. Nayab SN, Shinawi L, Hobkirk J, Tate TJ, Jones FH, Olsen I. Adhesion of bone cells to ion-implanted titanium. J Mater Sci: Mater Med 2003;14:991-997.
14. Nayab SN, Jones FH, Olsen I. Human alveolar bone cell adhesion and growth on ion-implanted titanium. J Biomed Mater Res A 2004;69:651-657.
15. Nayab SN, Jones FH, Olsen I. Effects of calcium ion implantation on human bone cell interaction with titanium. Biomaterials 2005;26:4717-4727.
16. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987;20:263-272.
17. Mackie EJ. Osteoblasts: Novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 2003;35:1301-1305.
18. Boskey AL. Noncollagenous matrix proteins and their role in mineralization. Bone Miner 1989;6:111-123.
19. Denhardt DT, Guo X. Osteopontin: A protein with diverse functions. FASEB J 1993;7:1475-1482.
20. Mundy GR. Local control of bone formation by osteoblasts. Clin Orthop Relat Res 1995;313:19-26.
21. Suzawa M, Takeuchi Y, Fukumoto S, Kato S, Ueno N, Miyazono K, Matsumoto T, Fujita T. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology 1999;140:2125-2133.
22. Kirkpatrick CJ, Wagner M, Kohler H, Bittinger F, Otto M, Klein CL. The cell and molecular biological approach to biomaterial research: A perspective. J Mater Sci Mater Med 1997;8:131-141.
23. Nayab SN, Jones FH, Olsen I. Modulation of the human bone cell cycle by calcium ion-implantation of titanium. Biomaterials 2007;28:38-44.
24. Armitage DA, Mihoc R, Tate TJ, McPhail DS, Chater R, Hobkirk JA, Shinawi L, Jones FH. The oxidation of calcium implanted titanium in water; A depth profiling study. Appl Surf Sci 2007;253:4085-4093.
25. Clover J, Gowen M. Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 1994;15:585-591.
26. Zreiqat H, Howlett CR. Titanium substrata composition influences osteoblastic phenotype: In vitro study. J Biomed Mater Res 1999;47:360-366.
27. Zreiqat H, Akin FA, Howlett CR, Markovic B, Haynes D, Lateef S, Hanley L. Differentiation of human bone-derived cells grown on GRGDSP-peptide bound titanium surfaces. J Biomed Mater Res A 2003;64:105-113.
28. Ku CH, Pioletti DP, Browne M, Gregson PJ. Effect of different Ti-6A1-4V surface treatments on osteoblasts behaviour. Biomaterials 2002;23:1447-1454.
29. Sumner H, Abraham D, Bou-Gharios G, Plater-Zyberk C, Olsen I. Simultaneous measurement of cell surface and intracellular antigens by multiple flow cytometry. Immunol Methods 1991;136:259-267.
30. Oosterhoff JK, Kuhne LC, Grootegoed JA, Blok LJ. EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2. Int J Cancer 2005;113:561-567.
31. Jayanthi S, Lewis BD, Cadet JL. Fas-induced apoptosis of glioma cells is associated with down-regulation of the hSCO1 protein, a subunit of complex IV. Brain Res Mol Brain Res 2001;91:131-136.
32. Szuts V, Mollers U, Bittner K, Schurmann G, Muratoglu S, Deak F, Kiss I, Bruckner P. Terminal differentiation of chondrocytes is arrested at distinct stages identified by their expression repertoire of marker genes. Matrix Biol 1998;17:435-448.
33. Crossin KL, Tai MH, Krushel LA, Mauro VP, Edelman GM. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci USA 1997;94:2687-2692.
34. Kuru L, Parkar MH, Griffiths GS, Newman HN, Olsen I. Flow cytometry analysis of gingival and periodontal ligament cells. J Dent Res 1998;77:555-564.
35. Dukas K, Sarfati P, Vaysse N, Pradayrol L. Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction. Anal Biochem 1993;215:66-72.
36. Krupa D, Baszkiewicz T, Kozubowski IA, Barcz A, Sobczak IW, Biliniski A, Rajchel B. Effect of calcium-ion implantation on the corrosion resistance and biocompatibility of titanium. Biomaterials 2001;22:2139-2151.
37. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004;16:291-299.
38. Korchynskyi O, ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 2002;277:4883-4891.
39. Miyazono K. Signal transduction by bone morphogenetic protein receptors: Functional roles of Smad proteins. Bone 1999;25:91-93.
40. Scherer A, Graff JM. Calmodulin differentially modulates Smad1 and Smad2 signaling. J Biol Chem 2000;275:41430-41438.
41. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials 2000;21:667-681.
42. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-1061.
43. Schneider GB, Zaharias R, Stanford C. Osteoblast integrin adhesion and signaling regulate mineralization. J Dent Res 2001;80:1540-1544.
44. Roach HI. Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption. Cell Biol Int 1994;18:617-628.
45. Schneider GB, Perinpanayagam H, Clegg M, Zaharias R, Seabold D, Keller J, Stanford C. Implant surface roughness affects osteoblast gene expression. J Dent Res 2003;82:372-376.
46. Takeuchi K, Saruwatari L, Nakamura HK, Yang JM, Ogawa T. Enhanced intrinsic biomechanical properties of osteoblastic mineralized tissue on roughened titanium surface. J Biomed Mater Res A 2005;72:296-305.
47. Knabe C, Howlett CR, Klar F, Zreiqat H. The effect of different titanium and hydroxyapatite-coated dental implant surfaces on phenotypic expression of human bone-derived cells. J Biomed Mater Res A 2004;71:98-107.
48. Ku CH, Pioletti DP, Browne M, Gregson PJ. Effect of different Ti-6A1-4V surface treatments on osteoblasts behaviour. Biomaterials 2002;23:1447-1454.
49. Zreiqat H, Akin FA, Howlett CR, Markovic B, Haynes D, Lateef S, Hanley L. Differentiation of human bone-derived cells grown on GRGDSP-peptide bound titanium surfaces. J Biomed Mater Res A 2003;64:105-113.
50. Butler WT. The nature and significance of osteopontin. Connect Tissue Res 1989;23:123-136.
51. Goldberg HA, Hunter GK. The inhibitory activity of osteopontin on hydroxyapatite formation in vitro. Ann N Y Acad Sci 1995;760:305-308.
52. Johnson GA, Burghardt RC, Bazer FW, Spencer TE. Osteopontin: Roles in implantation and placentation. Biol Reprod 2004;69:1458-1471.
53. Hanawa T, Asami K, Asaoka K. Microdissolution of calcium ions from calcium-ion-implanted titanium. Corros Sci 1996;38:1579-1594.
54. Hanawa T, Asami K, Asaoka K. AES studies on the dissolution of surface oxide from calcium-ion-implanted titanium in nitric acid and buffer solutions. Corros Sci 1996;38:2061-2067.
55. Sul YT, Johansson CB, Jeong Y, Roser K, Wennerberg A, Albrektsson T. Oxidized implants and their influence on the bone response. J Mater Sci Mater Med 2001;12:1025-1031.
56. Feng B, Weng J, Yang BC, Qu SX, Zhang XD. Characterization of titanium surfaces with calcium and phosphate and osteoblast adhesion. Biomaterials 2004;25:3421-3428.
57. Pham MT, Matz W, Reuther H, Richter E, Steiner G, Oswald S. Surface sensitivity of ion implanted titanium to hydroxyapatite formation. J Mater Sci Lett 2000;19:443-445.
58. Pham MT, Matz W, Reuther H, Richter E, Steiner G, Oswald S. Ion beam sensitizing of titanium surfaces to hydroxyapatite formation. Surf Coat Technol 2000;128:313-319.
59. Krupa D, Baszkiewicz I, Kozubowski IA, Barcz A, Sobczak JW, Biliński A, Lewandowska-Szumie M, Rajchel B. Effect of dual ion implantation of calcium and phosphorus on the properties of titanium. Biomaterials 2005;26:2847-2856.
60. Hanawa T. In vivo metallic biomaterials and surface modifications. Mater Sci Eng A 1999;267:260-266.
61. Becker P, Neuman HG, Zeggel P. Resorbable calcium phosphate coatings on orthopaedic and dental implants. Eur Soc Biomat 2001;16:78.
62. Berrere F, Habibovic P, van Blitterswijk CA, deGroot K, Layrolle P. Preparation of biomimetic calcium carbonate caotings on Ti6A14V. Eur Soc Biomat 2001;16:77.